<div id="readability-page-1">10:29 AM EDT, 05/18/2026 (MT Newswires) -- Eli Lilly ( LLY ) was among the pharmaceutical firms highlighted in Monday's Supreme Court order list, which included widespread denials of certiorari in drugmaker-related and other commercial cases, according to the Court's May 18 orders.The Court vacated and remanded several cases, including voting rights disputes, while rejecting review in multiple pharmaceutical and healthcare-related petitions, reducing the likelihood of near-term Supreme Court intervention in those matters.The Court granted review in one education case while denying dozens of appeals across civil, criminal, regulatory, and healthcare matters, with Justice Sotomayor separately concurring in the denial of certiorari in a sentencing case in which relief had already been granted.Shares of Eli Lilly ( LLY ) were down 2.2% in Monday trading.Price: 985.25, Change: -19.68, Percent Change: -1.96 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

礼来

2 倍做多 LLY ETF - Defiance

纳斯达克生物科技指数 ETF - iShares Nasdaq

礼来在被最高法院拒绝的制药公司中，该法院驳回了与医疗保健和商业案件相关的多项上诉。此决定降低了最高法院在这些问题上立即介入的可能性。消息公布后，礼来的股价下跌了 2.2%，至 985.25 美元

Eli Lilly Among Petitioners Denied Certiorari as Supreme Court Rejects Multiple Appeals

fidelity

Invesco Nasdaq Biotechnology ETF

医疗业 ETF - SPDR

医疗业 ETF - Vanguard

医药突破 ETF - ALPS

1 倍做空 LLY ETF - Direxion

Defiance Daily Target 2X Short LLY ETF

动态生物技术与基因组 ETF - Invesco

基因改革 ETF - ARK

标普生物技术 ETF - SPDR

美国制药 ETF - iShares

2 倍做多 LLY ETF - Direxion

标普生物技术 3 倍做多 - Direxion

标普生物技术 3 倍做空 - Direxion

标普全球医疗股指数 ETF - iShares

2 倍做多纳斯达克生物技术 ETF - ProShares

生物科技 ETF - VanEck Vectors

纽交所高增长板生物技术指数 ETF - First Trust

礼来公司等申请者在最高法院拒绝多项上诉时被拒绝受理申请